Inivata is a Leader in Liquid Biopsy

Unlocking essential genomic information from a simple
blood draw to transform the care of cancer patients

Inivata is a Leader in Liquid Biopsy

Unlocking essential genomic information from a simple
blood draw to transform the care of cancer patients

Our Technology

InVision® platform

Our InVision® platform unlocks essential genomic information from a simple blood draw to transform the care of cancer patients

Learn More

Our Solutions

InVisionFirst®Lung

Our US Medicare-reimbursed lead product InVisionFirst®Lung is already transforming the lives of advanced NSCLC patients

Find out More

Radar™

A multi-tumor assay for the detection of residual disease and recurrence based on the InVision® liquid biopsy platform

Discover Radar™

Our Mission

We are transforming the lives of cancer patients and their families through the power of liquid biopsy

Find out More

InvisionFirst Lung - ctDNA Liquid Biopsy Test

Partnerships

Our Technology

Contact Us

Latest News and Events

Inivata and collaborators to present data that further validate the application of its RaDaR™ MRD and InVisionFirst®-Lung assays at the ESMO Congress 2021

9 Sep 2021

Inivata, a leader in liquid biopsy, will present new data on its RaDaR assay for the detection of molecular residual disease (MRD) and ... Read More

More News

Preliminary results of the Liquid Biopsy for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS) study

6 Jul 2021

Susanne Flach, Karen Howarth, Sophie Hackinger, Christodoulos Pipinikas, Kirsten McLay, Giovanni Marsico, Christoph Walz, Olivier ... Read More

More Publications

2021 CB & CDx Digital Event

Event expiration date display - 29 - 30 SEPT 2021

Location: Online Event Read More

More Events

Changing Lives

Patients are at the heart of everything we do.

Our first product is for advanced Non-Small Cell lung Cancer and our world-leading tests are already impacting patients’ lives.

This is the story of the first patient Inivata tested.

Find out More

Transforming the lives of Cancer Patients and Their Families

As a dynamic and innovative company, we focus on the development of ground-breaking technology in a fast-paced and international setting.

Our team of talented and driven individuals work together to combine their energy and expertise in world-class research, product development and commercialization. Join us.

See our latest open roles

@inivata

September 15, 2021

The World Clinical Biomarkers and CDx Summit is taking place later this month. @Timforshew and Greg Jones will be presenting on 30th September amongst a host of other great speakers. Register now here:
https://world-cdx.com/take-part/register/ #WorldCDx @WorldCDx

September 14, 2021

It’s been a privilege to have taken part in the @IASLC over the past few days, and to listen to some fascinating presentations both from a variety of experts in the #lungcancer space, as well as individuals living with lung cancer.
Learn more: https://wclc2021.iaslc.org
#WCLC21

September 13, 2021

#TeamInivata is #recruiting! If making a difference is in your DNA, we want to hear from you. Join the #liquidbiopsy revolution and view our open roles here: http://www.inivata.com/careers/